ArticleBMC nursing2026
The effect of the integrated stress response reduction intervention on cellular aging in middle-aged nurses: a pilot study.
Article in BMC nursing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundNurses experience persistently high levels of occupational stress, which negatively impacts their health and the quality of patient care. Chronic psychological stress is closely linked to physiological dysregulation and cellular aging processes through stress-response pathways. However, limited evidence exists regarding whether stress management interventions targeting these mechanisms can influence cellular aging biomarkers in nurses. This study evaluated the effects of an Integrated Stress Response Reduction Intervention (iSRI) on cellular aging among middle-aged nurses.
methodsA non-randomized controlled pilot study was conducted with 60 nurses aged 45-60 years recruited from two tertiary hospitals. Participants were allocated to either an intervention group (n = 31) or a control group (n = 29). The 12-week iSRI comprised biofeedback, cognitive-behavioral education, mindfulness, and exercise. Outcomes included perceived stress levels and biochemical markers (serum cortisol, IL-6, and SOD). Cellular aging was assessed via leukocyte telomere length (LTL) and mitochondrial DNA copy number (mtDNAcn) using qPCR.
resultsFollowing the intervention, the iSRI group showed a significant decrease in perceived stress levels, with a significant group ⋅ time interaction (p =.012). Regarding biochemical markers, serum cortisol showed a significant group ⋅ time interaction (p =.001), although no significant between-group difference was observed post-intervention. SOD levels increased significantly in the intervention group compared to the control group (p =.031), showing a robust interaction effect (p =.001). Regarding cellular aging markers, a significant between-group difference in LTL was observed post-intervention (p =.002), and this difference remained significant after controlling for covariates (p =.047). However, the longitudinal effect for LTL was not statistically significant (p =.263). No significant changes were observed in IL-6 and mtDNAcn.
conclusionsThe 12-week iSRI demonstrated an initial protective effect on preserving LTL, which was associated with reductions in perceived stress and subsequent improvements in cortisol and SOD. These findings suggest that mechanism-based stress management may help support telomere preservation, a hallmark of cellular aging. Given the exploratory nature of this pilot study, further larger-scale randomized controlled trials are warranted to confirm whether such interventions can induce sustained shifts in biological aging trajectories. TRAIL REGISTRATION: The study was registered in CRIS (KCT0011526; registration date: 23 January 2026; retrospectively registered).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.